More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling

P Bader; E Salzmann-Manrique; A Balduzzi; JH Dalle; AE Woolfrey; M Bar; MR Verneris; MJ Borowitz; NN Shah; N Gossai; PJ Shaw; AR Chen; KR Schultz; H Kreyenberg; L Di Maio; G Cazzaniga; C Eckert; Vincent van der Velden; R Sutton; A Lankester; C Peters; TE Klingebiel; AM Willasch; SA Grupp; MA Pulsipher

doi:10.1182/bloodadvances.2019000449

More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling

P Bader, E Salzmann-Manrique, A Balduzzi, JH Dalle, AE Woolfrey, M Bar, MR Verneris, MJ Borowitz, NN Shah, N Gossai, PJ Shaw, AR Chen, KR Schultz, H Kreyenberg, L Di Maio, G Cazzaniga, C Eckert, Vincent van der Velden, R Sutton, A LankesterC Peters, TE Klingebiel, AM Willasch, SA Grupp, MA Pulsipher

Immunology

Research output: Contribution to journal › Article › Academic › peer-review

87 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	3393-3405
Number of pages	13
Journal	Blood advances
Volume	3
Issue number	21
DOIs	https://doi.org/10.1182/bloodadvances.2019000449
Publication status	Published - 2019

Research programs

EMC MM-02-72-01

Access to Document

10.1182/bloodadvances.2019000449

http://hdl.handle.net/1765/121570

Cite this

Bader, P., Salzmann-Manrique, E., Balduzzi, A., Dalle, JH., Woolfrey, AE., Bar, M., Verneris, MR., Borowitz, MJ., Shah, NN., Gossai, N., Shaw, PJ., Chen, AR., Schultz, KR., Kreyenberg, H., Di Maio, L., Cazzaniga, G., Eckert, C., van der Velden, V., Sutton, R., ... Pulsipher, MA. (2019). More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling. Blood advances, 3(21), 3393-3405. https://doi.org/10.1182/bloodadvances.2019000449

@article{2cb33a0040224e708c4a49558d35818d,

title = "More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling",

author = "P Bader and E Salzmann-Manrique and A Balduzzi and JH Dalle and AE Woolfrey and M Bar and MR Verneris and MJ Borowitz and NN Shah and N Gossai and PJ Shaw and AR Chen and KR Schultz and H Kreyenberg and {Di Maio}, L and G Cazzaniga and C Eckert and {van der Velden}, Vincent and R Sutton and A Lankester and C Peters and TE Klingebiel and AM Willasch and SA Grupp and MA Pulsipher",

year = "2019",

doi = "10.1182/bloodadvances.2019000449",

language = "Undefined/Unknown",

volume = "3",

pages = "3393--3405",

journal = "Blood advances",

issn = "2473-9529",

publisher = "American Society of Hematology",

number = "21",

}

Bader, P, Salzmann-Manrique, E, Balduzzi, A, Dalle, JH, Woolfrey, AE, Bar, M, Verneris, MR, Borowitz, MJ, Shah, NN, Gossai, N, Shaw, PJ, Chen, AR, Schultz, KR, Kreyenberg, H, Di Maio, L, Cazzaniga, G, Eckert, C, van der Velden, V, Sutton, R, Lankester, A, Peters, C, Klingebiel, TE, Willasch, AM, Grupp, SA & Pulsipher, MA 2019, 'More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling', Blood advances, vol. 3, no. 21, pp. 3393-3405. https://doi.org/10.1182/bloodadvances.2019000449

TY - JOUR

T1 - More precisely defining risk peri-HCT in pediatric ALL: pre- vs post-MRD measures, serial positivity, and risk modeling

AU - Bader, P

AU - Salzmann-Manrique, E

AU - Balduzzi, A

AU - Dalle, JH

AU - Woolfrey, AE

AU - Bar, M

AU - Verneris, MR

AU - Borowitz, MJ

AU - Shah, NN

AU - Gossai, N

AU - Shaw, PJ

AU - Chen, AR

AU - Schultz, KR

AU - Kreyenberg, H

AU - Di Maio, L

AU - Cazzaniga, G

AU - Eckert, C

AU - van der Velden, Vincent

AU - Sutton, R

AU - Lankester, A

AU - Peters, C

AU - Klingebiel, TE

AU - Willasch, AM

AU - Grupp, SA

AU - Pulsipher, MA

PY - 2019

Y1 - 2019

U2 - 10.1182/bloodadvances.2019000449

DO - 10.1182/bloodadvances.2019000449

M3 - Article

C2 - 31714961

SN - 2473-9529

VL - 3

SP - 3393

EP - 3405

JO - Blood advances

JF - Blood advances

IS - 21

ER -